Dr Ranga Sudhakar, CEO, APEIRON Healthcare

Dr Ranga Sudhakar, CEO, APEIRON Healthcare 

Closing the Distance Between Doctors and Patients

There is a road in rural India, unpaved and unnamed on most maps, that a mobile hospital now travels. It unfolds into a multi-speciality diagnostic unit, bringing families something they have waited a lifetime for: a qualified doctor, a laboratory, a specialist consultation, all arriving at their doorstep instead of demanding a hundred-kilometre journey in the other direction. That vehicle exists because one man refused to accept the distance between world-class medicine and the people who need it most as a permanent condition.

Dr Ranga Sudhakar, CEO of APEIRON Healthcare, has spent thirty years closing that distance, one unpaved road at a time. His credentials span a PhD from the University of France to conceptualising Asia’s first dual-sided expandable container, multi-speciality diagnostic mobile mini hospital. But credentials, he is quick to point out, are only useful if they travel. He sat down with our editorial team to discuss the architecture of India’s healthcare gap, the uncomfortable truths about public-private partnerships, and the problem that, after three decades, still keeps him up at night.

A PhD from France, yet most of your work has been in tribal India and remote last-mile delivery. How do you bridge that gap?

The academic frameworks I absorbed in France were never meant to be blueprints for corporate hospital chains. Their real value lies in understanding global healthcare markets in their entirety, and specifically remote healthcare, which is where India’s most urgent deficit sits. What I took away from those years was a conviction that world-class services and last-mile delivery are not opposites; they are obligations that must meet each other halfway.

When primary healthcare, diagnostics, and specialist consultations are absent at the community level, hospital referrals become the default, overwhelming tertiary care facilities with patients who could have been treated far earlier and closer to home. My work has always been about closing that gap, using telemedicine and doorstep delivery to bring services to people before a manageable condition becomes a crisis.

You conceptualised Asia’s first expandable mobile mini hospital. What can telemedicine still not solve?

The essence of the initiative is this: take last-mile healthcare delivery as close as possible to the patient’s doorstep. India has a network of CHCs, PHCs, sub-centres, and urban clinics that are, in principle, a sound foundation for primary care. In practice, the number that are genuinely functional and accessible remains a serious challenge; that gap is what the mobile unit addresses.

But the vehicle is only one part of the answer. What you carry inside it matters as much as where you park it. People in rural and tribal areas, unable to access qualified care, routinely turn to over-the-counter medicines, a habit that creates complications far worse than the original ailment. The mobile unit makes something qualitatively different possible: a qualified doctor consultation, laboratory analysis, multi-speciality diagnostics, specialist second opinions via telemedicine, and a proper referral mechanism when escalation is genuinely needed. Telemedicine connects a screen to a specialist. The mobile unit connects a patient to an entire system.

Where do you see the PPP model heading, and what structural flaw does nobody in policy circles openly admit?

Government programmes signal intent, but sustainability and last-mile reach remain the harder questions. Opening initiatives is one thing; following them through to the last beneficiary is another conversation entirely.

The PPP model, executed well, is among the most sustainable frameworks available; you can only clap with two hands. Corporate hospital networks have the bandwidth to partner with government at scale, but there’s a structural tension policy circles rarely name openly: those same networks have a vested interest in maintaining urban footfall. Strengthen primary care in remote areas, triage people effectively at the community level, and hospital admissions in cities will fall. Until that commercial contradiction is honestly addressed in how partnerships are designed, scaling PPP will remain difficult.

I have personally executed one of the largest such programmes in a state where daily patient volumes grew from twenty or thirty to over a hundred per centre, simply by making all primary services available at the point of care. That model needs to travel nationwide.

What does genuine healthcare leadership in India demand today that it didn’t a decade ago?

A decade ago, leadership meant building capacity, more hospitals, more beds, more specialists. Today, the demands are structural and philosophical in equal measure. Commercial imperatives have reshaped the doctor-patient relationship in ways that deserve honest scrutiny; elaborate diagnostic panels now precede prescriptions routinely, reflecting revenue cycles rather than clinical need.

Meanwhile, government healthcare infrastructure is, in physical footprint, genuinely strong. The problem is operationalising it — poor management, manpower gaps, and the absence of sustainable goals leave well-built facilities underutilised. Real leadership demands the courage to address both simultaneously: commercial distortions in the private sector and operational failures in the public sector. Underpinning everything is a rising disease burden that only preventive care and early detection can meaningfully contain.

Thirty years in, what healthcare problem still keeps you awake at night?

My answer is not complex, though far from simple to execute. The most urgent need is to make every government facility, including sub-centres, PHCs, CHCs, urban clinics, and the entire cascading network, fully operational, through direct management or the PPP model. Strengthen primary care, and the burden on district hospitals will reduce dramatically. India also has an enormous workforce of health workers whose potential remains largely untapped. Support them, train them, direct them purposefully, and the ambitions of this conversation become achievable.

What keeps me awake is this: until that foundational system is fully operational, every other initiative targeting specific ailments is a temporary patch, one that redirects funds away from something that could be permanent.